Navigation Links
Uroplasty to Present at the 11th Annual JMP Securities Research Conference
Date:5/7/2012

MINNEAPOLIS, May 7, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President and CFO, will present the Company's business strategy and financial results at the 11th Annual JMP Securities Research Conference at 12:30 pm PT on Monday, May 14, 2012 at the Ritz-Carlton Hotel in San Francisco.

Attendance at the conference is by invitation only. A live audio webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at http://wsw.com/webcast/jmp17/upi/, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.For Further Information:Uroplasty, Inc.

EVC Group David Kaysen, President and CEO, or

Doug Sherk/Jenifer Kirtland (Investors), 415.568.9349Medi Jiwani, Vice President, CFO, Treasurer

Chris Gale (Media), 646.201.5431 952.426.6140
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty to Present at the 24th Annual ROTH Conference
2. Uroplasty Announces Enrollment of First Patients in the CONFIDeNT Clinical Study for Treatment of Fecal Incontinence with Urgent® PC
3. Uroplasty Reports Third Quarter of Fiscal 2012 Financial Results
4. Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
5. Uroplasty to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference
6. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
7. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
8. Uroplasty to Issue Second Quarter 2012 Financial Results on October 27, 2011
9. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
10. Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012
11. Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016 Two new disaster ... in a simulated mass casualty event Tuesday at John ... The technology debuted before an audience including ... representatives from Homeland Security, Federal Law Enforcement Agencies, and ... known as HiRO (Health Integrated Rescue Operations), was developed ...
(Date:12/6/2016)... 6, 2016  Regulus Therapeutics Inc. (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, ... its R&D day, held in New ... an anti-miR targeting microRNA-27 (miR-27) for the treatment ... an anti-miR targeting microRNA-17 (miR-17) for the treatment ...
(Date:12/6/2016)... DIEGO , Dec. 6, 2016 /PRNewswire/ ... on the development of Conditionally Active Biologic ... and Beijing Sinobioway Group Company, Limited (Sinobioway) ... for development.  The specific program candidates and ... March 2015, BioAtla and Sinobioway entered into ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... ... Why does the prevalence of obesity continue to increase worldwide? Some would say lifestyle, ... cause of obesity in his new book “Body Weight Regulation.” , “Body Weight ... healthy life. Proietto said understanding the regulation of body weight and the causes of ...
(Date:12/6/2016)... Alpharetta, GA (PRWEB) , ... December 06, 2016 ... ... list of largest patient satisfaction measurement firms. The ranking is based on ... healthcare organizations such as hospitals, health systems, ambulatory surgical centers, clinically integrated networks, ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle ... 15, 2017 to apply for a 2016/2017 California Casualty Thomas R. Brown Athletics ... Qualifying schools can receive up to $3,000. , The grant is named ...
(Date:12/6/2016)... ... December 06, 2016 , ... United ... to announce it has added CXC Solutions (CXC) as a new Strategic Partner. ... solutions are tailored to help benefits advisors reduce operating costs and generate additional ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, one of the ... counting and sizing services for USP 788 and 789 particulate standards compliance. The ... a response to the needs of pharmaceutical and medical device manufacturers, who are ...
Breaking Medicine News(10 mins):